StarBIA conducts and publishes research with universities, research institutes and hospitals in the field of body composition technologies, including bioelectrical impedance analysis from simple whole-body single-frequency mode to professional multi-segmental, multi-frequency mode. At this stage, StarBIA’s bioelectrical impedance analysis products are under Class II medical device applications of the Taiwan Food and Drug Administration (TFDA), the US Food and Drug Administration (USFDA), China Food and Drug Administration (CFDA) and the EU Medical Device Directive (MDD).
Vision: Be the first class and leading service provider in body composition
Purpose: Create new devices and services that benefit for human health and meet the health and medical needs of diverse populations.
Core Values: Practical research, Honesty, Public wellness, and Innovation